The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals.

Tamborrini, Marco; Schäfer, Anja; Hauser, Julia; Zou, Linghui; Paris, Daniel H; Pluschke, Gerd

Tamborrini, Marco; Schäfer, Anja; Hauser, Julia; Zou, Linghui; Paris, Daniel H; Pluschke, Gerd.

Affiliation

Tamborrini M; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Schäfer A; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
Hauser J; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Zou L; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
Paris DH; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Pluschke G; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.

Malar J ; 22(1): 210, 2023 Jul 15.

Article in En | MEDLINE | ID: mdl-37454145

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parasites / Malaria, Falciparum / Malaria Vaccines Limits: Animals / Humans Language: En Journal: Malar J Journal subject: MEDICINA TROPICAL Year: 2023 Document type: Article Affiliation country: Suiza Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google